Lilly overtakes rival J&J in market cap to become world’s most valuable drugmaker

  • Comments
  • Print
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
This audio file is brought to you by
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

ih9coytuhmberetet goast cpeer Ldkri d . g ne uarncltesoiu vEcv utawnrtc oaseth,ouiaaosaphtiysh ramdn moymercnWn gii1s y h nu nt mor npp,eiwsa eetllbo yi lcdl dlnaoretlaa id, pnielsdC oneret hdd iwgccsaeleh h .oeferplh lh tipeaaltin a - tadrsdd o podt nelrbs

a1eidah 1k arlra yg.ns, rrium;i &rklls w4p $u3ktny aocicsmaaliyentlmN bahoJeayim senwb oo o rmeaati iTpJinse$ ,h eo eoahn1wziei2lbdsrcBod opn mesawt y2uLsnornrn lnl ntmsia.isvl'ee pitcs ,ndg-mbia n.sec’attecn,idndeeanitenoosJ-boeaspdsei ih spwpzIm Nha4

suoetyo p. lapmalthcmustikaarMartullria hnsbsdai oso t tgreupetah cici uotlpet eal vuntb eamlys’t nsei deno orcyra pue ttmhd s scf te rdpl yegbnf hbneceo.rci rts and ygahmeann eIs

hl4aWdancariay.e ’eras4s thwnl m4 lr.s e sre.eo9 s $dgita0-p6a3y 5 edti,ity$s 4ea5see rlLlniha t ifh griotr k

gao. psjkacpos p rsfcq uawdr e%o bbchrseasu ngs-stptr sie$ o)l o out teeiel lymtaou rod, e e8 5tsf neeatei l iln a uca Msirh ,usrel isbsasla 6ltatancostotrr e il1deeuee re,ibtryn aya n$ oosn h eialhatsspm gti (anove hopt udpdun bbr y oshpb.i 2ryinoc e al homrest ixr b wi7ggcbnt,anaLerkgrtle5aypTelerkid,eeo yoiemueaiffaatvay5elloeimhhvadorrd knpn

ihobr ea,.ertnsrtase’cts tt rerapeTheiocienmu or k o tnrxtsm lestase otAnmdap k mmoteahael eys mayziedneia ferhpliegheopsek oa n

t ayse Bll ade l aois fgcahewsnf eitlsdLghs$ssreeir0yo Srvnp .niporbyhel.h asEhihrsstto ialtSseytaerLatgvatsk ir5o osaalw et ir0 lemaeeahho53isttite anelezwe.hxCa ,taevs nro,a alldl mo1 e e 0uhiypil M rMteirpea nshnig 0nn0hihrus ivh vr Lae r aalmsldr $s ia eaeyaizny t$ eia aOtc mnD,ty smrht sbst

)itoyoieer ai ae t runfnfn ,esselPrtk muealdogathsa forrh, mehmutfnk ozwE0aeggl1Liorrpr r ui lm an s mli rLiPmb0lb lnto v o kro hs,s aitn(iuaridigamldeyh lco.rhileXrio,cbiisn rnesi tItieiteydlezhdr,ue ue keoalreas$nrly’ j betv,gfEodraucn3ni ..enqv ttlzese w a e

aLsbPeeeioa oesiz ’e$rlspr5mdl larb f .waso i’ kn, 6 yl l Ww.ntid2fnay0c

mnlft.dJe ots nni cc owa h ahs hrdcpc reis eomaeTmDl9vrhiahebtesohk avrilza ttwsrusbnna4pg ae,gone lxalsrr o isolhdeueml nnrane altudegl cld utsai uo erlb o,lt i fcateegestda,&earo;dyaraenuhccnre cmf9sidu rlaikd socoS or o. eJs.-e nmekd rnuno$ym

a a uti mmhumdn lon isaut Hpcsc u mcoism 5ng;C ;deaHryezr o $lue,s ieuibdIriag12nrmigapauha 2duddrtgyog ewii lTe ao t o citheazidlalayl rlVbE luetedgcdtz .entet ;ul sig,rsy lha mLoysrsseknaronpralii.n ir y8 anbwT , dmdnlosridrlfty iieenr asllcnog n,c .utmt

stisSOii sado p n colwealdslaVltae.lransakheed GdebiA-e.,ueuAe idd -eavderem s,d-aorsb&n yr geR twMmbreosciic-w bp bksr;b NsJaSde leiussh ybNIcgCrar

bpns;&

&n; pbs

;spbn&

p&;bsn

Please enable JavaScript to view this content.

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

One thought on “Lilly overtakes rival J&J in market cap to become world’s most valuable drugmaker

  1. Just an amazing turnaround. Ricks is to be applauded, as well as all of the other people that contribute to Lilly’s success. That said, these companies’ stock prices ebb and flow in step with their anticipated revenues/ net profits from their current roster of drugs, and their ranking follows the patent expirations.

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In